Literature DB >> 8995707

Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR.

K Nagai1, A H Wong, S Li, W N Tam, A R Cuddihy, N Sonenberg, M B Mathews, J Hiscott, M A Wainberg, A E Koromilas.   

Abstract

Replication of the human immunodeficiency virus type 1 (HIV-1) is inhibited by interferons (IFNs), and the IFN-inducible protein kinase PKR is thought to mediate this effect by regulating protein synthesis. Here we report that ectopic expression of dominant negative PKR mutants in Jurkat cells induces HIV-1 replication. Specifically, expression of CD4 is upregulated by the PKR mutants, and this correlates with an induction of HIV-1 binding and proviral DNA synthesis upon HIV-1 infection. Moreover, activation of NF-kappaB was induced by an RNA binding-defective mutant of PKR. Thus, it appears that PKR, in addition to translational control, is involved in HIV-1 replication by modulating virus binding through the regulation of CD4 expression and virus gene expression through the activation of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995707      PMCID: PMC191238     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI.

Authors:  S R Green; M B Mathews
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

2.  The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins.

Authors:  T G Lee; N Tang; S Thompson; J Miller; M G Katze
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

Review 3.  Chemokine receptors and HIV-1: an attractive pair?

Authors:  P Bates
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

4.  Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages.

Authors:  C F Perno; A Bergamini; C D Pesce; G Milanese; M Capozzi; S Aquaro; S Thaisrivongs; W G Tarpley; G Zon; C D'Agostini
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

5.  Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.

Authors:  Y Shirazi; P M Pitha
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

6.  Human PKR transfected into murine cells stimulates expression of genes under control of the HIV1 or HTLV-I LTR.

Authors:  E F Meurs; N McMillan; B R Williams; A G Hovanessian; P J Southern
Journal:  Virology       Date:  1995-12-20       Impact factor: 3.616

7.  TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR.

Authors:  H Park; M V Davies; J O Langland; H W Chang; Y S Nam; J Tartaglia; E Paoletti; B L Jacobs; R J Kaufman; S Venkatesan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B.

Authors:  A Kumar; J Haque; J Lacoste; J Hiscott; B R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

9.  Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras.

Authors:  A Maran; R K Maitra; A Kumar; B Dong; W Xiao; G Li; B R Williams; P F Torrence; R H Silverman
Journal:  Science       Date:  1994-08-05       Impact factor: 47.728

10.  Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase.

Authors:  E F Meurs; J Galabru; G N Barber; M G Katze; A G Hovanessian
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more
  7 in total

1.  A cis-acting element in the 3'-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR.

Authors:  F Osman; N Jarrous; Y Ben-Asouli; R Kaempfer
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

2.  The IFITM proteins inhibit HIV-1 infection.

Authors:  Jennifer Lu; Qinghua Pan; Liwei Rong; Wei He; Shan-Lu Liu; Chen Liang
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

3.  PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex.

Authors:  M C Bonnet; R Weil; E Dam; A G Hovanessian; E F Meurs
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

4.  Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection.

Authors:  Haitao Hu; Martin Nau; Phil Ehrenberg; Agnes-Laurence Chenine; Camila Macedo; Yu Zhou; Z John Daye; Zhi Wei; Maryanne Vahey; Nelson L Michael; Jerome H Kim; Mary Marovich; Silvia Ratto-Kim
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

5.  A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Weiming Wang; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

Review 6.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

7.  PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone.

Authors:  Ana Maria Rivas-Estilla; Yuri Svitkin; Marcelo Lopez Lastra; Maria Hatzoglou; Averell Sherker; Antonis E Koromilas
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.